Table 7. Potential pitfalls of gene therapy for heart failure.
Detail |
---|
1. Inadequate gene transfer to the target cell – issues related to dose, vector, mode of delivery |
2. Elimination by the immune system – need for immunosuppression in some cases |
3. Liver sequestration |
4. Off-target effects |
5. Episomal degradation – long term gene expression desirable in heart failure patients |
6. Limited scale up capacity of gene therapy medicinal products |